A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes

Clinical trial NCT07319845 · RECRUITING

Trial details

NCT number: NCT07319845
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2026-04-22
Primary completion: 2028-06-26
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.